1. Home
  2. RCUS vs LGN Comparison

RCUS vs LGN Comparison

Compare RCUS & LGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$19.64

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

LGN

Legence Corp.

N/A

Current Price

$57.84

Market Cap

2.4B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RCUS
LGN
Founded
2015
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
RCUS
LGN
Price
$19.64
$57.84
Analyst Decision
Buy
Strong Buy
Analyst Count
9
15
Target Price
$28.22
$44.90
AVG Volume (30 Days)
913.0K
917.7K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$247,000,000.00
N/A
Revenue This Year
N/A
$17.13
Revenue Next Year
N/A
$42.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$28.31
52 Week High
$26.40
$56.89

Technical Indicators

Market Signals
Indicator
RCUS
LGN
Relative Strength Index (RSI) 43.81 63.79
Support Level $8.86 $42.97
Resistance Level $21.55 N/A
Average True Range (ATR) 1.09 3.93
MACD 0.03 0.73
Stochastic Oscillator 36.70 99.88

Price Performance

Historical Comparison
RCUS
LGN

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About LGN Legence Corp.

Legence Corp is a provider of engineering, installation and maintenance services for mission-critical systems in buildings. It focuses on high-growth sectors that have technically demanding buildings, including technology, life sciences, healthcare and education. The company specializes in designing, fabricating and installing complex HVAC, process piping and other mechanical, electrical and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting and building controls in existing facilities to make them more energy efficient and sustainable.

Share on Social Networks: